Legal News

Pfizer Settles Class Action Suit for $486 Million
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

NEW YORK - JANUARY 26:  A Pfizer sign hangs on the outside of their headquarters after a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion creating the world's largest biopharmaceutical company.  (Photo by Mario Tama/Getty Images)

Photo courtesy of U.S. News. 

Summary: Pfizer has agreed to pay $486 million to settle a class action lawsuit with investors. 

After over a decade of fighting a lawsuit, drug giant Pfizer said on Tuesday that it has agreed to pay $486 million to settle. The company was sued by investors in 2004 for allegedly failing to disclose the dangers of its bestselling pain relievers, Celebrex and Bextra.

  
What
Where


The settlement resolves accusations from investors who claimed Pfizer failed to disclose that Celebrex and Bextra could increase a patient’s risk of heart attack or stroke. The investors who owned stock between October 31, 2001 to October 19, 2005 filed a class action lawsuit, and they said that Pfizer had concealed related tests that dated back as early as 1998.

Rival company Merck withdrew a similar drug because of heart risks, which triggered an inquiry into Bextra and Celebrex. The investors said that when Pfizer’s tests finally were made public, the prescription drugs’ stock plummeted by roughly $70 billion.

In the end, Pfizer pulled Bextra from the market in the United States.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




In September 2009, Pfizer settled with the federal government for $2.3 billion after a probe into the marketing of its drugs.

A spokesman for Pfizer said that the settlement is not an admission of guilt.



“This resolution reflects a desire by the company to avoid the distraction of continued litigation and focus on the needs of patients and prescribers,” Pfizer said.

Plaintiffs had sued Pfizer and its executives, including former Chief Executive Henry McKinnell.

What do you think of Pfizer and this case? Let us know in the comments below.

Source: Reuters



 

Interesting Legal Sites You May Like


BCG FEATURED JOB

Locations:

Keyword:



Search Now

Attorney with 7-10 years of business litigation experience

USA-CA-Century City

Small to mid-size Century City law firm is seeking an attorney with 7 - 10 years of business litigat...

Apply Now

Trust and Estate Attorney with 5-8 Years Experience

USA-MA-Wellesley

Mid-sized law firm in Wellesley is seeking a trust and estate attorney with 5-8 years of experience....

Apply Now

Project Finance and Energy Attorney with 6 years of experience

USA-IL-Chicago

Chicago office of top firm seeks class 2012 associate with energy and project finance experience.

Apply Now

IP Patent Prosecution Agent with 2-4 years of physics experience

USA-WI-Milwaukee

Milwaukee office of our client seeks IP patent prosecution agent with 2-4 years of experience. The c...

Apply Now

RELEVANT JOBS

Corporate / Commercial Attorney | Lebanon, NH

USA-NH-Lebanon

Downs Rachlin Martin PLLC seeks an experienced corporate / commercial attorney to join its Lebanon o...

Apply now

Business Law Junior Associate | Burlington, VT

USA-VT-Burlington

Downs Rachlin Martin seeks associate attorney with 1-3 years of experience to join its Commercial an...

Apply now

Business Law Associate | Burlington

USA-VT-Burlington

Downs Rachlin Martin is seeking an attorney with 4 to 8 years of experience to join its very busy pr...

Apply now

Trademark & Business Law Associate | Burlington, Vermont

USA-VT-Burlington

Downs Rachlin Martin PLLC (DRM) is seeking an Associate attorney with 1-3 years of trademark and tra...

Apply now

Most Popular

SEARCH IN ARCHIVE

To Top